A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens
Clinical trial NCT04238962 · COMPLETED
Trial details
- NCT number
- NCT04238962
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2020-10-20
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.